| Primary biliary cirrhosis EJ Carey, AH Ali, KD Lindor The Lancet 386 (10003), 1565-1575, 2015 | 676 | 2015 |
| Recent advances in the development of farnesoid X receptor agonists AH Ali, EJ Carey, KD Lindor Annals of translational medicine 3 (1), 5, 2015 | 283 | 2015 |
| Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience TT DeLeon, MA Salomao, BA Aqel, MB Sonbol, RT Yokoda, AH Ali, ... Journal of gastrointestinal oncology 9 (6), 1054, 2018 | 158 | 2018 |
| Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis AH Ali, JH Tabibian, N Nasser‐Ghodsi, RJ Lennon, T DeLeon, MJ Borad, ... Hepatology 67 (6), 2338-2351, 2018 | 132 | 2018 |
| Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease R Ramanathan, AH Ali, JA Ibdah International Journal of Molecular Sciences 23 (13), 7280, 2022 | 97 | 2022 |
| Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation OY Mousa, BD Juran, BM McCauley, MN Vesterhus, T Folseraas, ... Hepatology 74 (1), 281-295, 2021 | 81 | 2021 |
| Primary sclerosing cholangitis, part 1: epidemiology, etiopathogenesis, clinical features, and treatment JH Tabibian, AH Ali, KD Lindor Gastroenterology & hepatology 14 (5), 293, 2018 | 79 | 2018 |
| the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis JL Damman, EA Rodriguez, AH Ali, CW Buness, KL Cox, EJ Carey, ... Alimentary pharmacology & therapeutics 47 (7), 886-895, 2018 | 75 | 2018 |
| A randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis MG Silveira, AA Gossard, AC Stahler, RA Jorgensen, JL Petz, AH Ali, ... American journal of therapeutics 24 (2), e167-e176, 2017 | 66 | 2017 |
| Varices in early histological stage primary biliary cirrhosis AH Ali, E Sinakos, MG Silveira, RA Jorgensen, P Angulo, KD Lindor Journal of clinical gastroenterology 45 (7), e66-e71, 2011 | 60 | 2011 |
| Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis AH Ali, J Damman, SB Shah, Y Davies, M Hurwitz, M Stephen, LM Lemos, ... Scandinavian journal of gastroenterology 55 (8), 941-950, 2020 | 58 | 2020 |
| Obeticholic acid for the treatment of primary biliary cholangitis AH Ali, KD Lindor Expert opinion on pharmacotherapy 17 (13), 1809-1815, 2016 | 50 | 2016 |
| The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: a retrospective single-center study AH Ali, S Panchal, DS Rao, Y Gan, A Al-Juboori, S Samiullah, JA Ibdah, ... Journal of Ultrasound 23, 157-167, 2020 | 42 | 2020 |
| Current research on the treatment of primary sclerosing cholangitis AH Ali, EJ Carey, KD Lindor Intractable & rare diseases research 4 (1), 1-6, 2015 | 42 | 2015 |
| Primary sclerosing cholangitis, part 2: cancer risk, prevention, and surveillance JH Tabibian, AH Ali, KD Lindor Gastroenterology & hepatology 14 (7), 427, 2018 | 35 | 2018 |
| Diagnosis and management of primary biliary cirrhosis AH Ali, EJ Carey, KD Lindor Expert review of clinical immunology 10 (12), 1667-1678, 2014 | 33 | 2014 |
| Orphan drugs in development for primary biliary cirrhosis: challenges and progress AH Ali, TJ Byrne, KD Lindor Orphan Drugs: Research and Reviews, 83-97, 2015 | 31 | 2015 |
| The microbiome and primary sclerosing cholangitis AH Ali, EJ Carey, KD Lindor Seminars in liver disease 36 (04), 340-348, 2016 | 26 | 2016 |
| Primary sclerosing cholangitis AH Ali, KN Lazaridis Yamada's Textbook of Gastroenterology, 1745-1758, 2022 | 23 | 2022 |
| Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis JS Jang, BD Juran, KY Cunningham, VK Gupta, YM Son, JD Yang, AH Ali, ... Scientific reports 10 (1), 12584, 2020 | 23 | 2020 |
